by Sue Robbins | Nov 2, 2020 | Migraine
Treatment with fremanezumab, the fully humanized IgG2?a monoclonal antibody that selectively targets calcitonin gene-related peptide, significantly reduced the number of headache or migraine days experienced before therapy. These findings, from a pooled analysis of...
by Sue Robbins | Sep 22, 2020 | Miscellaneous
US cases of depression have tripled during the COVID-19 pandemic A large study finds a dramatic increase in the number of adults in the United States reporting symptoms of depression during the COVID-19 pandemic. Share on PinterestRecent data indicate that the number...
by Sue Robbins | Sep 18, 2020 | Miscellaneous
In Hard Times, a Barrage of Ads Promises Peace of Mind Meditation apps, tinctures, stress-busting gummies — spending on commercials for all of them is rising amid the pandemic’s climbing death toll and economic strain. A lethal pandemic and widespread unemployment...
by Sue Robbins | Jul 20, 2020 | Wellness
Many people who loathe exercise arguably feel that way because of how the activity has been marketed to them. For too long, exercise and weight loss have been indivisibly bound, leading many to fall into the comparison trap, experience shame or engage in...
by Sue Robbins | Jul 15, 2020 | Migraine
Compared with healthy control participants, pediatric patients with chronic migraine (CM) report a higher rate of depression, according to study findings published in Pediatric Neurology. Researchers suggested that clinicians should consider including therapy in...
